Thomas Lehrman
Managing Partner @ Teamworthy Ventures
New York, United States
Thomas Lehrman is a seed investor at Teamworthy Ventures in New York focused on Software and FinTech. Thomas D. Lehrman is the Board Director at Gerson Lehrman Group.He is a Co - Founder and former Co - Chief Executive Officer of Gerson Lehrman Group, Inc. Thomas Lehrman most recently served as Director of the Office of WMD Terrorism at the U.S. Department of State and previously as a member of the professional staff on the President's WMDCommission. Earlier in his career, he worked as a Financial Analyst at Tiger Management. He is also a Co - Founder & Board Member of the Brooklyn Excelsior Charter School and the Hillhouse Scholars Program. Thomas Lehrman is a Chartered Financial Analyst and graduated from Duke University and Yale Law School.
- Total investments:
- 42
- Last investment:
- Lead investor:
- 5%
Last updated:
For AI agents: llms.txt
Industries Thomas Lehrman invests in
Stages Thomas Lehrman invests in
Countries Thomas Lehrman invests in
Round sizes
Round size
- Seed
- $750k–$6M
- Series A
- $550k–$13M
- Series B
- $10M–$157M
Investment Focus
Industry
- Software 9 (21%)
- FinTech 6 (14%)
- Education 6 (14%)
- SaaS 5 (12%)
- Enterprise Software 5 (12%)
Stage
- Seed 20 (48%)
- Series A 8 (19%)
- Series B 6 (14%)
- Funding Round 3 (7%)
- Angel 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
OWL
|
OWL, also known as Old Well Labs, operates in the financial services, fintech, and information technology industries. The company provides a modern intelligence platform for global investors. It offers detailed profiles of leading allocators who control over $12 trillion in assets. Additionally, OWL holds the largest repository of global investmentmanager analytics. The company also takes full-scope technical ownership of the OWL product, ensuring its continuous development and improvement. | $4M / Venture - Series Unknown / Feb 27, 2026 | |
Drug Hunter
|
Drug Hunter™ is an essential subscription service for R&D-focused organizations turning molecules into medicines.Every day, drug discovery strategies, tactics, challenges and solutions are disclosed, but the knowledge is fragmented across journals, conferences, patents, databases, news, company reports, filings and endless other sources,making it challenging to find and apply.Drug Hunter’s experts keep you current by connecting the dots, distilling industry lessons from thousands of sources into a one-of-a-kind searchable platform for drug discovery knowledge you can apply to make better decisions and solve critical discovery challenges.Founded and run by a team of industry scientists, Drug Hunter now serves >200 innovative institutions worldwide including top pharma and biotech companies, investors, and non-profits. | $6M / Seed / Sep 15, 2025 | |
Journeyfront
|
Journeyfront is a Developer of a job recruitment platform designed to match people with their dream jobs. The company's platform uses predictive analytics, machine learning, and psychometric assessments to take the guesswork out of hiring so that people do not end up with wrong jobs and negatively impact their career and growth of companies,enabling job seekers to land up with appropriate jobs and companies to improve employee performance, remove hiring bias and increase their hiring speed. | $13.4M / Series A / Jan 12, 2022 | |
G2
|
G2 is a platform to share business software reviews in real-time. It leverages more than 1.3 million user reviews to drive better purchasing decisions. G2 is used by business professionals, buyers, investors, and analysts to select the best software and services based on peer reviews and synthesized social data.The company was founded in 2012 andis based out of Chicago, Illinois. | $157M / Series D / Jun 22, 2021 | |
|
G2
|
G2 is a platform to share business software reviews in real-time. It leverages more than 1.3 million user reviews to drive better purchasing decisions. G2 is used by business professionals, buyers, investors, and analysts to select the best software and services based on peer reviews and synthesized social data.The company was founded in 2012 andis based out of Chicago, Illinois. | $157M / Series B / Jun 22, 2021 | |
Abacum
|
Abacum is a SaaS that helps finance teams deliver business insights. Abacum is the first collaborative workflow and planning platform for SMB's finance teams to boost productivity and strategic impact. The company believes in empowering people with the best collaborative tools for them to multiply their strategic impact in the organization andbe more fulfilled. | $7M / Seed / Apr 08, 2021 | |
Lithic
|
Lithic utilizes virtual cards to allow consumers and businesses to prioritize privacy and safety and not compromise their sensitive financial information. Lithic makes it simple to create payment cards to enable and control spending. | $10.2M / Series A / Jul 15, 2020 | |
Literati
|
Based in Austin,Texas Literati is a subscription book club company. Since 2017, Literati has provided a unique try-before-you-buy book club service to kids 12 and under. Most recently the company has expanded its product line, offering book clubs curated by “luminaries,” a collection of authors, intellectuals, and other notable figures.Literati's team is made up of product people, perfectionistic designers, philosophical hackers, and straight-up hustlers on a mission to build revolutionary excitement in literature. The company was founded in 2017 and is based in Austin, Texas. | $12M / Series A / Oct 23, 2019 | |
Voro
|
VVoro is a developer of a doctor's recommendation platform designed to make community healthier. The company's platform permits users to find the right doctor, view recommendations they trust from people they know, like friends or co-workers and get their appointment booked via concierge, enabling them to find doctors easily viarecommendations. | $2.5M / Seed / Jul 08, 2019 | |
Qualified
|
Qualified is the most effective platform for evaluating and training world-class engineers. Utilizing real-world assessment methodology we enable companies to identify high-performing hires. | Seed / Dec 05, 2017 | |
| See all 42 investments → | |||
Co-Investors
About Teamworthy Ventures
At Teamworthy Ventures, we seek to develop long-term relationships with talented and trustworthy entrepreneurs and teams, and we invest in their ventures at the seed, early, or growth stage. We strive to be worthy partners by connecting promising entrepreneurs to our network of other successful entrepreneurs and partners to help them buildinnovative companies of purpose, value, and integrity. We assist our entrepreneurs with helpful introductions to new customers, partners, and team members.
Teamworthy Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Evan Kaye
Partner
|
|||
Harry Bound
Associate
|
|||
Kyle Limpic
Associate
|
|||
Melanie Ashmore
Head of Investor Relations / EA
|
|||
Stephen Schmalhofer
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Thomas Lehrman invest in?
Thomas Lehrman invests primarily in Software, FinTech and Education startups, most often at Seed and Series A stage. Most of the 42 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Thomas Lehrman's check size?
Thomas Lehrman typically joins rounds of $750k–$6M at Seed, $550k–$13M at Series A and $10M–$157M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Thomas Lehrman participates in.
When did Thomas Lehrman last invest?
The most recent investment recorded for Thomas Lehrman closed in Feb 2026. Shizune tracks 42 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
